| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.096 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.093 | 0.2 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.2 |